NCT00598689View on ClinicalTrials.gov

GenTeal in Perioperative Treatment of Laser Assisted in Situ Keratomileusis LASIK Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Corneal Epithelium Defect
Interventions
DRUG

0.3% hypromellose

0.3% hypromellose four times a day for 5 days prior to LASIK surgery

Trial Locations (1)

30907

EyeCare One, Augusta

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Augusta University

OTHER